To know the prevalence of lower extremity peripheral arterial disease (PAD) and peripheral neuropathy (PN) in diabetic patients, in AIMSR, Bathinda.

Dr Narayan  Jeet  Singh; Dr Madhu Lata Rana; Avtar Singh Bansal; Neetu Swain

Volume : VI, Issue : V, May - 2016

To know the prevalence of lower extremity peripheral arterial disease (PAD) and peripheral neuropathy (PN) in diabetic patients, in AIMSR, Bathinda.

Dr Narayan Jeet Singh, Dr Madhu Lata Rana, Avtar Singh Bansal, Neetu Swain

Abstract :

AIM AND OBJECTIVE: – To know the prevalence of lower extremity peripheral arterial disease (PAD) and peripheral neuropathy (PN) in diabetic patients and compare the result with non diabetic patients. MATERIAL AND METHODS: This is a retrospective study conducted in AIMSR, Bathinda, Punjab from 1st August 2014 .The study was carried out randomly in 1000 patients who attended medicine OPD or referred to surgery OPD from medicine OPD for the management of surgical complication of DM. Clearance from the institutional ethical committee was obtained for the study. INCLUSION CRITERIA: Patients of both gender male and female aged between ≥20 years to ≤ 70 years ,who were either a diagnosed case of diabetes or who presented with complain of calf pain in either leg while walking, or had numbness, loss of feeling , or painful sensations or tingling in their feet or any symptoms and signs suggestive of diabetes mellitus, were taken up randomly for the purpose of study Detailed history was taken and thorough clinical examination was done in all the patients.PAD and PN was assessed with the help of non invasive tests and duplex color Doppler study Assessment of PAD – This was done by determining the ABI. ABI is the ratio of systolic blood pressure in the ankles (posterior tibial vessel) to that in the right arm (right achial vessel). Measurements were taken in supine position. Patient were considered to be suffering from PAD if ABI was <0.9 in either leg and if ABI <0.7 then this indicated patients to be suffering from moderate to severe PAD. If the patient gets calf pain in either leg while walking then he/she was classified as symptomatic PAD Assessment of PN – PN was accessed by symptoms of numbness, loss of feeling or painful sensation or tingling in their feet and by a non invasive test with a standard mono filament (5.07–gauge Semmer–Weinsteen nylon). Pressure was applied with the mono–filament at three sites (Planter, first metatarsal head; Planter, fifth metatarsal head; Planter, hallux) on the bottom of each foot (i.e. a total of six sites). The site was considered insensate if on application of monofilament to the foot on three times, the participant incorrectly determined on two of three applications. Impaired sensation was quantified by the total number of insensate areas for both feet (range 0–6), and PN was classified as >1 insensate area. RESULTS: The study results are comparable to other studies. CONCLUSION: Diabetes mellitus increases the risk of PAD, PN almost two times than the overall population.